We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Seek Clarification on Efficacy Requirements for Pneumonia Drugs
Sponsors Seek Clarification on Efficacy Requirements for Pneumonia Drugs
May 8, 2014
Sponsors are praising the FDA’s efforts to loosen restrictions on trials for drugs that treat community-acquired bacterial pneumonia, but want clarification on what the agency expects to see for efficacy endpoints.